Minimization of proteome reallocation explains metabolic transition in hierarchical utilization of carbon sources
mSystems · 22.07.2025 · 10 (7)
DOI: 10.1128/msystems.00690-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 22.07.2025. Verfasst von Zhihao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Proteome, Carbon, Bacillus coagulans, Bacterial Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cells choose between alternative pathways in metabolic networks under diverse environmental conditions, but the principles governing the choice are insufficiently understood, especially in response to dynamically changing conditions. Here, we observed that the lactic acid bacterium Bacillus coagulans displayed homolactic fermentation on glucose or trehalose as the sole carbon source but transitioned from homolactic to heterolactic fermentation during the hierarchical utilization of glucose and trehalose when growing on the mixture. We simulated the observation by dynamic minimization of reallocation of the proteome (dMORP) using an enzyme-constrained genome-scale metabolic model, which coincided with our omics data. Moreover, we evolved strains to co-utilize mixed carbon sources and repress the choice of heterolactic fermentation, and the dynamics after co-utilization of carbon sources were also captured by dMORP. Altogether, the findings suggest that upon environmental changes, bacteria tend to minimize proteome reallocation and accordingly adjust metabolism, and dMORP would be useful in simulating cellular dynamics. IMPORTANCE Redundancy in metabolic networks empowers cells to choose between distinct metabolic strategies under changing environments. However, what drives the cellular choice remains poorly understood. We hypothesized that in response to rapid environmental changes, cells might minimize reallocation of the proteome and accordingly adjust metabolism. We found that this hypothesis could interpret a metabolic transition in the lactic acid bacterium Bacillus coagulans during the hierarchical utilization of glucose and trehalose, which was validated using systems biology approaches. Furthermore, we presented a framework with the objective function of minimizing proteome allocation, allowing for the simulation and understanding of cellular responses to dynamic perturbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
- State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
ORCID-Profile: Zhihao Liu, Yonghong Wang, Yu Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, Z., Chen, M., Hu, J., Wang, Y., & Chen, Y. (2025). Minimization of proteome reallocation explains metabolic transition in hierarchical utilization of carbon sources. mSystems, 10(7). https://doi.org/10.1128/msystems.00690-25
Vancouver
Liu Z, Chen M, Hu J, Wang Y, Chen Y. Minimization of proteome reallocation explains metabolic transition in hierarchical utilization of carbon sources. mSystems. 2025;10(7). doi:10.1128/msystems.00690-25
BibTeX
@article{Liu2025,
author = {Liu, Zhihao and Chen, Minghao and Hu, Jingmin and Wang, Yonghong and Chen, Yu},
title = {Minimization of proteome reallocation explains metabolic transition in hierarchical utilization of carbon sources},
journal = {mSystems},
year = {2025},
volume = {10},
number = {7},
doi = {10.1128/msystems.00690-25}
}
EUVIMED